Next Generation Antidepressants: Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders

Next Generation Antidepressants: Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders

ISBN-10:
0521760585
ISBN-13:
9780521760584
Pub. Date:
05/20/2010
Publisher:
Cambridge University Press
ISBN-10:
0521760585
ISBN-13:
9780521760584
Pub. Date:
05/20/2010
Publisher:
Cambridge University Press
Next Generation Antidepressants: Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders

Next Generation Antidepressants: Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders

$140.0 Current price is , Original price is $140.0. You
$140.00 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Overview

The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.

Product Details

ISBN-13: 9780521760584
Publisher: Cambridge University Press
Publication date: 05/20/2010
Series: Cambridge Medicine (Hardcover)
Pages: 150
Product dimensions: 6.20(w) x 9.30(h) x 0.60(d)

About the Author

Chad E. Beyer is Prinicpal Research Scientist II at Pfizer Global Research and Development, Princeton, New Jersey and Adjunct Professor at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California San Diego, San Diego, California, and Neuroscience Education Institute, Carlsbad, California, USA.

Table of Contents

Preface Chad E. Beyer; 1. Current depression landscape: a state of the field today Laurence Mignon and Stephen M. Stahl; 2. Novel therapeutic targets for treating affective disorders Eliyahu Dremencov and Thomas Cremers; 3. Developing novel animal models of depression Lotte de Groote, Malgorzata Filip and Andrew C. McCreary; 4. Translational research in mood disorders: using imaging technologies in biomarker research Jul Lea Shamy, Adam M. Brickman, Chris D. Griesemer, Anna Parachikova and Mark Day; 5. Defining depression endophenotypes Lisa H. Berghorst and Diego A. Pizzagalli; 6. Genetic and genomic studies of major depressive disorder Roy H. Perlis; 7. Medicinal chemistry challenges in the design of next generation antidepressants David P. Rotella; 8. Application of pharmacogenomics and personalized medicine for the care of depression Keh-Ming Lin, Chun-Yu Chen and Yu-Jui Yvonne Wan; Index.
From the B&N Reads Blog

Customer Reviews